1585 Results

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Scordo
    Scordo
  4. Shah
    Shah
  5. Dahi
    Dahi
  6. Ponce
    Ponce
  7. Sauter
    Sauter
  8. Devlin
    Devlin
  9. Shah
    Shah
  10. Papadopoulos
    Papadopoulos

Groups

  1. CTCR Scholars (1585)
  2. Department of Medicine (1369)
  3. Hematologic Malignancies, Division of (1045)
  4. MSK Grad Students (989)
  5. Master of Science in Clinical and Translational Cancer Research (956)
  6. Center for Hematologic Malignancies (955)
  7. Survivorship Research (885)
  8. Bone Marrow Transplant (841)
  9. Epidemiology and Biostatistics (671)
  10. Biostatistics Service (608)
  1. "CTCR Scholars"
Formats
  1. Meeting Abstract (846)
  2. Journal Article (546)
  3. Review (68)
  4. Research Letter (35)
  5. Editorial (29)
  6. Correspondence (24)
  7. Miscellaneous (16)
  8. Book Section (10)
  9. Guidelines (7)
  10. Conference Paper (4)
Groups
  1. CTCR Scholars (1585)
  2. Department of Medicine (1369)
  3. Hematologic Malignancies, Division of (1045)
  4. MSK Grad Students (989)
  5. Master of Science in Clinical and Translational Cancer Research (956)
  6. Center for Hematologic Malignancies (955)

More Groups

People
  1. Sergio Giralt (539)
  2. Miguel-Angel Perales (397)
  3. Michael Scordo (366)
  4. Gunjan Shah (321)
  5. Sean Devlin (321)
  6. Parastoo Dahi (294)

More People

Years
  1. 2025 (68)
  2. 2024 (227)
  3. 2023 (261)
  4. 2022 (230)
  5. 2021 (166)
  6. 2020 (211)

More Years

Publications
  1. Blood (294)
  2. Biology of Blood and Marrow Transplantation (187)
  3. Journal of Clinical Oncology (140)
  4. Annals of Surgical Oncology (81)
  5. Bone Marrow Transplantation (65)
  6. Transplantation and Cellular Therapy (55)

More Publications

Publishers
  1. Elsevier Inc. (390)
  2. American Society of Hematology (345)
  3. American Society of Clinical Oncology (153)
  4. Nature Publishing Group (130)
  5. Springer (98)
  6. American Association for Cancer Research (65)

More Publishers

Results (1585)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identifying causes of unscheduled healthcare interactions and changes to patient disposition in individuals receiving outpatient commercial bispecific antibody therapy in relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Howard, A. J.; Shekarkhand, T.; Hamadeh, I. S.; Wang, A.; Patel, D.; Tan, C.; Hultcrantz, M.; Mailankody, S.; Hassoun, H.; Shah, U. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Real-world outcomes in patients with transformed follicular lymphoma treated with CD19-targeting CAR-T therapy
    Meeting Abstract

    Rivas-Delgado, A.; Luttwak, E.; Drill, E.; Goldstein, I.; Landego, I.; Tomas, A. A.; Parascondola, A.; Saldia, A.; Caron, P.; Dahi, P. B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A whole foods plant-based weight loss intervention improves quality of life, metabolic, microbiome and immune profile in MGUS/SMM as well as progression trajectory in a subset - the Nutrivention trial
    Meeting Abstract

    Shah, U. A.; Castro, F.; Derkach, A.; Fei, T.; Hosszu, K. K.; McAvoy, D.; DeWolf, S.; Cross, J.; Gradissimo, A.; Nwankwo, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The composite health risk assessment model (CHARM) to predict 1-year non-relapse mortality (NRM) among older recipients of allogeneic transplantation: A prospective BMT-CTN study 1704
    Meeting Abstract

    Artz, A.; Logan, B. R.; Saber, W.; Geller, N.; Bellach, A.; Kou, J.; Wood, W.; McCarty, J. M.; Knight, T. G.; Runaas, L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Patient-reported outcomes in the phase 3 CARTITUDE-4 study of ciltacabtagene autoleucel vs standard of care in patients with lenalidomide-refractory multiple myeloma after 1-3 lines of therapy
    Meeting Abstract

    Mina, R.; Mylin, A. K.; Yokoyama, H.; Magen, H.; Alsdorf, W.; Minnema, M. C.; Shune, L.; Isufi, I.; Harrison, S. J.; Shah, U. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Trem-cel, a CRISPR/Cas9 gene-edited allograft lacking CD33, shows rapid primary engraftment with CD33-negative hematopoiesis in patients with high-risk acute myeloid leukemia (AML) and avoids hematopoietic toxicity during gemtuzumab ozogamicin (GO) maintenance post-hematopoietic cell transplant (HCT)
    Meeting Abstract

    DiPersio, J.; Cooper, B. W.; Suh, H. C.; Koura, D.; Bernard, L.; Shah, N. N.; Walter, R. B.; Perales, M. A.; Mapara, M.; Tamari, R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Updated findings of a phase II study of ruxolitinib pre-, during- and post-hematopoietic stem cell transplantation for patients with primary or secondary myelofibrosis
    Meeting Abstract

    Hobbs, G. S.; Kim, H. T.; O'Connor, S.; Schroeder, M. A.; Tamari, R.; Wall, S. A.; El-Jawahri, A.; McAfee, S.; Hem, J.; Lozano, P.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A personalized whole genome-informed assay targeting single mutant in circulating tumor DNA can identify MRD and predict relapse in DLBCL
    Meeting Abstract

    Merryman, R. W.; Rhoades, J.; Xiong, K.; Antel, K.; An, H. H.; Redd, R. A.; McDonough, M. M.; Guerrero, L.; Crnjac, A.; Sridhar, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of investigational microbiome therapeutic SER-155 on pathogen domination: Initial results from a phase 1b study in adults undergoing allogeneic hematopoietic cell transplantation (HCT)
    Meeting Abstract

    Peled, J. U.; van den Brink, M. R. M.; Ponce, D. M.; Kosuri, S.; Khera, N.; DeFilipp, Z.; Tejura, B.; Lichter, D. I.; Lombardo, M. J.; Wortman, J. R.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Outcomes in mantle cell lymphoma with central nervous system involvement - A dual center study
    Meeting Abstract

    McLaughlin, N.; Joseph, A.; Wang, Y. C.; Pederson, L. D.; Geyer, S. M.; Witzig, T. E.; Zelenetz, A. D.; Villasboas, J. C. C.; Scordo, M.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save